Yes PoS, I'm wondering if that is a significant up-front attached to a stomper new deal or if it's talking about Roche taking the BBB peptide under a new full licensing agreement & structured into a new comercial deal. You never know maybe both :-) and more :-)
Another thing worth remembering here is PYC's role is not necessarily in the development of new drugs but simply providing the carrier to get these already developed drugs to their target either one that is currently classed as undruggable or simply a much more efficent & effective method of delivery. Basically means some of these partnerships might reach their endpoint & big cash return phase much much faster than those associated with new drugs & the lengthy drug discovery process with drawn out clinical trials over many years.
PYC Price at posting:
6.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)